Refractory Celiac Disease: Nutritional Failure, Immune Dysregulation, and Lymphomagenesis
Nutrients · 31.07.2026 · 18 (15) · 2479
DOI: 10.3390/nu18152479 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.07.2026. Verfasst von Ioanna Aggeletopoulou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Celiac Disease, Lymphoma, Malnutrition, Enteropathy-Associated T-Cell Lymphoma. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Refractory celiac disease (RCeD) is a rare but severe complication of celiac disease characterized by persistent or recurrent malabsorptive symptoms and villous atrophy despite a strict gluten-free diet, after exclusion of ongoing gluten exposure, alternative enteropathies, and overt lymphoma. RCeD comprises two biologically distinct entities. RCeD-I is associated with phenotypically normal, polyclonal intraepithelial lymphocytes and generally reflects persistent gluten-independent mucosal inflammation with a relatively favorable prognosis. RCeD-II is defined by expansion of aberrant clonal intraepithelial lymphocytes lacking normal surface T-cell markers and is increasingly regarded as a low-grade intraepithelial lymphoma or in situ lymphomatous disorder, with substantial risk of progression to enteropathy-associated T-cell lymphoma (EATL). Mechanistic studies identify epithelial stress, IL-15-driven IEL survival, stromal and innate immune amplification, and cytotoxic epithelial injury as central drivers of refractory mucosal damage. In RCeD-II, aberrant IELs acquire a hybrid T/NK-like phenotype, persist through anti-apoptotic IL-15/JAK–STAT signaling, and induce enterocyte killing, while molecular alterations involving JAK1, STAT3, JAK/STAT regulators, NF-κB signaling, epigenetic regulators, and chromosomal abnormalities support stepwise lymphomagenesis. Recent single-cell multiomic studies further reveal genetically altered intestinal lymphocyte clones and intratumoral heterogeneity across the RCeD-II–EATL continuum. From a nutritional immunology perspective, RCeD illustrates a setting in which removal of the initiating dietary antigen is insufficient to restore mucosal immune homeostasis. This review summarizes the pathogenic processes that distinguish RCeD-I from RCeD-II and link failed mucosal recovery after gluten withdrawal to persistent immune-mediated epithelial injury, aberrant IEL expansion, clonal evolution, and lymphoma progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece.
- 4th Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokratio Hospital, 54642 Thessaloniki, Greece.
ORCID-Profile: Ioanna Aggeletopoulou, Ploutarchos Pastras, Maria Kalafateli, Christos Triantos
Zitieren
APA
Aggeletopoulou, I., Pastras, P., Kalafateli, M., & Triantos, C. (2026). Refractory Celiac Disease: Nutritional Failure, Immune Dysregulation, and Lymphomagenesis. Nutrients, 18(15), 2479. https://doi.org/10.3390/nu18152479
Vancouver
Aggeletopoulou I, Pastras P, Kalafateli M, Triantos C. Refractory Celiac Disease: Nutritional Failure, Immune Dysregulation, and Lymphomagenesis. Nutrients. 2026;18(15):2479. doi:10.3390/nu18152479
BibTeX
@article{Aggeletopoulou2026,
author = {Aggeletopoulou, Ioanna and Pastras, Ploutarchos and Kalafateli, Maria and Triantos, Christos},
title = {Refractory Celiac Disease: Nutritional Failure, Immune Dysregulation, and Lymphomagenesis},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {15},
pages = {2479},
doi = {10.3390/nu18152479}
}
EUVIMED